kt-333
kymera therapeutics
['leusm', 'leukemia', 'kt-333 ', 'lymphoma']
congress #asco22 | alexander starodub discusses kt-333 a stat-3 degrader in a phase ia trial (n=40) in pts with r/r lymphomas looking for the rp2d. a phase ib trial (n=80) will explore safety, pk, pd &amp; clinical activity of kt-333 in pts with lgl #leukemias #leusm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm